Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy

E-ISSN： 1873-4286|18|11|1465-1477

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.11, 2012-04, pp. : 1465-1477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammatory lipids as a target for therapy in the rheumatic diseases

By McMahon Maureen Brahn Ernest

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 8, 2008-08 ,pp. : 1213-1224

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for cardiovascular diseases

By Brugada R. Roberts R.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1385-1393

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for cardiovascular diseases

By Snowden M.M. Grove R.I.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 509-520

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. : 407-423

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy in Cardiovascular Diseases

Current Gene Therapy, Vol. 2, Iss. 4, 2002-12 ,pp. : 427-435

Bentham Science Publishers

Access to resources Recommend Favorite